Which of the following drug has visual field defects as an adverse effect?
Cabergoline
Bromocriptine
Pegvisomant
Leuprolide
Pegvisomant is GH receptor antagonist Known to cause visual field defect. Pegvisomant given subcutaneously cause toxicity:increase liver enzymes Also known as somatotropin antagonist Bromocriptine and Cabergoline are D2 receptor agonists Leuprolide is GnRH agonist
Pituitary-Hypothalmic System and Thyroid